Azotobacter ͉ Isc ͉ IscU ͉ scaffold ͉ IscS
I
ron-sulfur [Fe-S] clusters are small inorganic prosthetic groups that participate in a variety of biochemical processes, including electron transfer, substrate binding and activation, redox catalysis, DNA replication and repair, regulation of gene expression, and tRNA modification (1, 2) . The most abundant [Fe-S] clusters fall into two structural types, rhombic [2Fe-2S] and cubane [4Fe-4S], and these clusters are typically attached to their protein partners, called [Fe-S] proteins, through cysteine thiolate ligands. Despite their simple composition and structure, biological formation of [Fe-S] clusters is remarkably complex, a feature that could be related to the physiological toxicity of Fe 2ϩ and S 2Ϫ in their free forms. The canonical [Fe-S] protein maturation machinery found in many bacteria and most, if not all, eukaryotes is called the iron-sulfur cluster (ISC) system (1, 3) . In Azotobacter vinelandii, this system includes a proposed [Fe-S] cluster assembly scaffold (IscU), a sulfur-trafficking pyridoxal 5Ј-phosphate (PLP)-dependent cysteine desulfurase (IscS), molecular chaperones (HscB and HscA), a ferredoxin (Fdx), a possible Fe donor or auxiliary [Fe-S] cluster assembly/ carrier protein (IscA), a protein of unknown function (IscX), and a regulatory protein (IscR) (4) . Although details of the assembly process are not known, the current model proposes that [Fe-S] clusters are formed on IscU through the delivery of S by IscS and the delivery of Fe by an unknown mechanism. HscB and HscA are proposed to be involved in the subsequent delivery of [Fe-S] clusters from IscU to various target proteins (5, 6) . The ISCassociated ferredoxin has been proposed to be involved in the formation of different cluster types on IscU and/or the redoxdependent release of [Fe-S] clusters from IscU. It also has been suggested that auxiliary [Fe-S] cluster carrier proteins could be involved in the distribution of [Fe-S] clusters assembled on IscU to other target proteins (7, 8) .
Although there is a substantial body of evidence that [Fe-S] clusters can be assembled on the proposed IscU scaffold in vitro (9, 10) , validation of the ''scaffold hypothesis'' for the formation of simple [Fe-S] clusters has not been clearly established by in vivo methods. Furthermore, nothing is known about the dynamic aspects of in vivo [Fe-S] cluster assembly. The in vivo analysis of [Fe-S] cluster assembly presents a number of technical challenges. For example, because [Fe-S] clusters are destined for delivery to other proteins, they are expected to be readily detached from the assembly scaffold after in vivo assembly is complete. This possibility is supported by the observation that [Fe-S] clusters assembled on IscU in vitro are both reductively and oxidatively labile (9) . Also, the physiological accumulation of ISC components is subject to a negative feedback regulatory mechanism in response to a demand for [Fe-S] protein maturation. This situation is expected to result in a very low physiological accumulation of [Fe-S] cluster assembly intermediates. In the present work, these problems were circumvented in several ways. First, an A. vinelandii strain was constructed that has expression of ISC components decoupled from IscR regulation, such that the expression of ISC components exceeds the physiological demand for [Fe-S] protein maturation. Using this genetic background, a second strain was constructed that produces a physiologically active form of IscU that contains an affinity tag, which permits the rapid and gentle purification of IscU. Finally, a third strain that carries an amino acid substitution within IscU, which results in a dominant-negative phenotype, was constructed. Isolation of IscU produced by these different strains permitted a direct test of the scaffold hypothesis and also provided insights about the mechanistic features of the in vivo [Fe-S] cluster assembly process.
Results

Genetic Constructions and Experimental
Rationale. In the case of A. vinelandii, the genetic manipulation of ISC components is complicated by the fact that iscS, iscU, hscB, hscA, and fdx are essential (11) . Therefore, we previously constructed a strain (DJ1421) that has a duplicate copy of iscS, iscU, iscA, hscB, hscA, and fdx placed under control of the inducible sucrose catabolic regulatory (SCR) elements (Fig. 1) . Thus, the phenotypic consequences of substitutions placed in any of the endogenous ISC components can be assessed by growing cells in the presence of sucrose, a condition under which the duplicated ISC region is expressed, or in the absence of sucrose, a condition under which the duplicated ISC region is not expressed. DJ1421 was used for all other strain constructions in this work (11) .
Previous attempts to isolate an [Fe-S] cluster-loaded form of IscU from a wild-type strain of A. vinelandii were not successful. Among possible explanations that could contribute to this failure is that ISC expression is subjected to a negative feedback loop (12) . Namely, once the demand for [Fe-S] cluster biosynthetic capacity is satisfied, IscR represses further expression of the ISC transcriptional unit. Therefore, we reasoned that expression of ISC components at a level that exceeds the demand for maturation of [Fe-S] proteins could result in the accumulation of an [Fe-S] cluster-loaded form of IscU. To accomplish the elevated expression of ISC components, a strain (DJ1601) (Fig. 1) was constructed that has an in-frame deletion within the iscR gene. An important aspect of this experimental strategy is that it permits the elevated expression of ISC components, but not at the extreme, nonphysiological levels commonly associated with heterologous recombinant expression. This strategy also has the advantage that the coordinate expression of all of the ISC components remains intact. Thus, artifacts that might be anticipated to result from the hyperexpression or unbalanced expression of ISC components are avoided. The consequence of placing a deletion within iscR was assessed by comparing the ␤-gal activity in a strain that has an hscA::lacZ fusion and an intact iscR gene (DJ1525) with an isogenic strain that also carries an iscR deletion (DJ1580). This analysis revealed that loss of IscR function results in a 5-to 7-fold increase in ISC expression. Western blot analysis using anti-IscU antibodies also indicated that deletion of iscR results in an Ϸ4.5-fold elevated expression of IscU (data not shown).
A second anticipated problem associated with the isolation of [Fe-S] cluster-loaded forms of IscU produced in vivo is the expected lability of the associated [Fe-S] clusters (9) . Thus, it was necessary to develop a method for the rapid and gentle purification of IscU from cell extracts. To accomplish this goal, strain DJ1697 was constructed (Fig. 1) ; it encodes a polyhistidine tag within the C-terminal coding region of iscU in combination with an in-frame deletion in iscR. This construction permitted the application of immobilized metal affinity chromatography (IMAC) for rapid purification of IscU as described in the next section. It also was necessary to establish that the incorporation of the polyhistidine tag within the C-terminal coding region of IscU does not adversely affect the in vivo function of IscU. This hypothesis was tested by showing that strain DJ1697 has the same growth rate either when cultured using sucrose as the carbon source, a condition under which the SCR-regulated untagged version of IscU also is expressed, or using glucose as the carbon source, a condition under which only the IscR-regulated, tagged copy of IscU is expressed (data not shown). We also found that incorporation of the polyhistidine tag at the C-terminal region of IscU has no adverse effect on the accumulation of active aconitase, a [4Fe-4S] cluster-dependent enzyme, indicating that the tag does not impair the in vivo capacity for maturation of [Fe-S] proteins (data not shown).
A final genetic construction involved the substitution of the Asp 39 residue by Ala in the polyhistidine-tagged version of IscU in a genetic background for which iscR also is deleted (DJ1766) (Fig. 1 ). This strain is unable to grow in the absence of sucrose, indicating that the Ala 39 substitution eliminates the function of IscU. Previous work with a similar strain revealed that substitution of the IscU Asp 39 residue by Ala 39 results in a dominantnegative phenotype (very slow growth) when the wild-type SCR-regulated allele of iscU also is expressed (11) . The dominant-negative effect of the IscU Ala 39 substitution also is manifested by a 70% loss in the activity of aconitase. In previous studies, it was shown that in vitro assembly of [2Fe-2S] clusters using the Ala 39 -substituted form of IscU from A. vinelandii (10), or the analogous substitution within IscU from other organisms (13, 14) , results in the stabilization of the associated [2Fe-2S] cluster compared with wild-type IscU. Thus, one explanation for the dominant-negative effect exhibited by DJ1766 is that stable [Fe-S] cluster species become trapped on the proposed IscU scaffold in vivo and are, therefore, unavailable for [Fe-S] protein maturation. Another possibility is that the IscU Ala 39 substitution could result in sequestering some other component of the ISC biosynthetic machinery within a nonproductive complex. Construction of DJ1766 was designed to elucidate the basis for the dominant-negative phenotype associated with the IscU Ala 39 substitution.
Labile [Fe-S] Clusters Are Assembled on IscU in Vivo.
The histidinetagged version of IscU was isolated in two steps that involved IMAC and anion-exchange chromatography. Fractions eluted from the IMAC column containing IscU were analyzed by SDS/PAGE and also were found to contain substoichiometric amounts of IscS (data not shown). Pooled fractions that contained IscU were then applied to an anion-exchange column and eluted using a salt gradient. Anion-exchange chromatography resolved the sample into three major fractions designated I, II, and III (Fig. 2) . Fraction I is colorless (Fig. 3A) , exhibits no distinctive absorbance in the visible spectrum (Fig. 3B) , and contains only IscU ( Fig. 3C) (15) . When fraction I was further analyzed by gel-filtration chromatography, it was resolved into two fractions that correspond to mono-and dimeric forms of IscU. The monomeric form of IscU was usually the predominant species, but the relative amount of monomer and dimer varied from experiment to experiment (data not shown). Chemical analysis of fraction I indicated that it contains Ϸ0.21 (Ϯ0.01) Fe and 0.18 (Ϯ0.01) acid-labile sulfide per IscU. Fraction II is red (Fig. 3A) , only contains IscU (Fig. 3C ), and exhibits a UV-visible absorption spectrum (Fig. 3B ) that has identical features compared with the [2Fe-2S] cluster-loaded IscU produced by in vitro reconstitution methods. The maximum extinction coefficients for this sample were 456 ϭ 6.0 mM Ϫ1 cm Ϫ1 and 410 ϭ 6.6 mM Ϫ1 cm Ϫ1 , and these values are similar to those reported for [2Fe-2S] cluster-containing ferredoxins (16) . When fraction II was analyzed by gel filtration, it also could be resolved into apparent monomers and dimers, although the monomeric species was predominant. Chemical analysis of fraction II indicated that it contains Ϸ1.29 (Ϯ0.05) Fe and 1.14 (Ϯ0.29) acid-labile sulfide per IscU. The [2Fe-2S] species contained within IscU prepared in vivo is rapidly destroyed when exposed to air (Fig.   Fig. 1 .
Schematic representation of strains used in this article. Strains DJ1601, DJ1697, and DJ1766 each carries a 120-bp in-frame deletion within the iscR gene (filled triangles). Strains DJ1697 and DJ1766 produce an IscU that carries a polyhistidine tag located at the C terminus. The His-tagged version of IscU produced by DJ1766 also has the Asp 39 residue substituted by Ala (filled dot).
Fig. 2.
Anion-exchange chromatography elution profile of the IscUcontaining IMAC fraction prepared from DJ1697: Apo-IscU (fraction I), [Fe-S] cluster-loaded IscU (fraction II), and IscS (fraction III).
4), and this same feature has been reported for [2Fe-2S] species assembled on IscU by in vitro methods (9) . Fraction III was identified as IscS by Western blot analysis and because it has the same UV-visible absorption spectrum and the same electrophoretic mobility as previously reported for IscS, it contains PLP, and it exhibits cysteine desulfurase activity.
Isolation of a Stable [Fe-S] Cluster-Loaded Noncovalent ␣2␤2 IscU-IscS
Complex. The Ala 39 -substituted form of IscU produced by DJ1766 was subjected to a purification procedure very similar to the one described above. In this case, anion-exchange chromatography yielded a single brown fraction, in contrast to the colorless and red fractions described above (see Fig. 3A ). SDS/PAGE and quantitative amino acid analysis revealed that IscU-Ala 39 and IscS are isolated as a nearly exact stoichiometric complex (Fig. 3C) . The identity of IscU Ala 39 and IscS purified from DJ1766 extracts was further established by mass spectrometry. Size-exclusion chromatography indicated that the IscUAla 39 -IscS complex has an approximate M r of 127,000, which is consistent with the complex being comprised of an ␣ 2 ␤ 2 heterotetramer. Chemical analysis of the complex showed that it contains Ϸ1.2 (Ϯ0.2) Fe and 0.95 (Ϯ0.1) acid-labile sulfide per IscU and Ϸ0.9 (Ϯ0.2) PLP per IscS. Subtraction of the UVvisible spectrum of the [2Fe-2S] cluster-loaded form of IscU (Fig. 3B, spectrum 2 ) from the IscU-Ala 39 -IscS complex (Fig.  3B, spectrum 3 ) yields the same characteristic spectrum associated with isolated IscS. Furthermore, subtraction of an equivalent IscS spectrum from the IscU-Ala 39 -IscS complex spectrum (Fig. 3B, spectrum 3 ) yields a spectrum that has the same features as the [2Fe-2S] cluster-loaded form of IscU (Fig. 3B) . Thus, it can be concluded that the IscU-Ala 39 -IscS complex is likely to be loaded with predominantly a [2Fe-2S] cluster, although the presence of other [Fe-S] species has not been excluded. This question will be addressed by future biophysical analyses. In contrast to the oxidative lability of the [2Fe-2S] cluster present in isolated IscU, the [Fe-S] species contained within the IscU-Ala 39 -IscS complex is not degraded on prolonged exposure to oxygen (Fig. 4) .
In separate experiments, we also tested whether an [Fe-S] cluster-loaded form of the A. vinelandii IscU-Ala 39 -IscS complex is produced when these proteins are heterologously expressed at high levels by using recombinant plasmid gene expression in Escherichia coli. In this case, IscU-Ala 39 and IscS also are isolated as a tight complex even in the presence of the reducing agent DTT, but the complex does not contain an [Fe-S] species. These results underscore the difficulty in obtaining meaningful physiological insight when using either high-level or unbalanced expression of [Fe-S] cluster assembly components. Nevertheless, the result obtained here using heterologously produced IscU Ala 39 and IscS indicates that an [Fe-S] cluster is not required to stabilize the nondissociating complex. Addition of L-cysteine to as-isolated IscS results in a rapid and characteristic shift in the visible absorption spectrum (Fig. 5A ) (4, 17) . This spectral shift most likely represents a stage in the initial formation of the external PLP substrate aldimine or the reformation of the internal PLP aldimine upon the release of alanine (17) . This feature was used to estimate the affinity of L-cysteine for IscS by titrating the spectral shift with increasing concentrations of L-cysteine (Fig. 5C ). It should be noted that an accurate K d value (estimated K d Ϸ 0.6 mM) could not be determined by this method because substrate binding is inhibited at high concentrations of L-cysteine (Fig. 5C) (4) . Addition of L-cysteine to the IscU-Ala 39 -IscS complex also results in the same spectral shift recognized for isolated IscS (compare spectra in Fig. 5 A and B) , and titration with L-cysteine (Fig. 5C ) reveals that both IscS and the IscU-Ala 39 -IscS complex have approximately the same affinity for L-cysteine. After elicitation of the spectral shift as a result of L-cysteine addition, the as-isolated spectrum is regenerated in a time-dependent manner, as shown in Fig. 5D , corresponding to the desulfurization of L-cysteine. Although the specific rate-limiting step in the overall cysteine desulfurization reaction for class I IscS-type enzymes is not known (e.g., substrate C-S bond cleavage, persulfide cleavage, H abstraction, or L-alanine release), it is clear that the formation of the enzyme-substrate complex is not rate-limiting. Data presented in Fig. 5D also show that regeneration of the asisolated spectrum after L-cysteine addition occurs Ϸ12 times slower for the IscU-Ala 39 -IscS complex (k ϭ 0.0035 s Ϫ1 ) compared with IscS (k ϭ 0.03 s Ϫ1 ). Whether this feature represents 2, and 3) . IscU in lane 3 has a faster electrophoretic mobility compared with lanes 1 and 2 because it carries the Ala 39 substitution. Unlabeled lane: Mr standards (ovalbumin, 45,000; carbonic anhydrase, 31,000; soybean trypsin inhibitor, 21,500; lysozyme, 14,400). a change in the same rate-limiting step for the complex compared with IscS is not known. However, it can be concluded that, although L-cysteine has approximately the same affinity for IscS as for the IscU-Ala 39 -IscS complex, a subsequent step in the desulfurization reaction is slowed when IscS is captured in a complex with IscU.
Discussion
Our first experimental strategy was to ask whether an [Fe-S] cluster-loaded form of IscU accumulates on the proposed IscU scaffold in vivo under conditions for which the intact [Fe-S] cluster biosynthetic machinery exceeds the demand for [Fe-S] protein maturation. The answer to this question is yes, and, importantly, the [Fe-S] species that accumulates on IscU under these conditions exhibits a UV-visible absorption spectrum line shape that is identical to that of the [2Fe-2S] cluster-loaded form of IscU produced by in vitro reconstitution experiments (15).
Thus, the present article validates the physiological relevance of previous in vitro studies on the assembly of [Fe-S] clusters on the proposed IscU scaffold. Previous work also has reported on the isolation of a cluster-loaded form of an IscU-like protein produced in vivo, but this study involved an extremely high level of heterologous expression of the recombinant IscU-like protein in the absence of other assembly components (14) . The present work is different because: (i) IscU was not produced recombinantly in a heterologous host, (ii) the [2Fe-2S] cluster-loaded form of IscU was isolated from samples that did not involve the hyperproduction of IscU, and (iii) the balanced expression of the other IscR-regulated [Fe-S] protein maturation components remained intact. Thus, potential artifacts that could be associated with heterologous or hyperexpression of IscU, or the unbalanced expression of other ISC components, have been avoided.
The work described herein also shows that different forms of IscU representing different stages in the process of [Fe-S] cluster assembly can accumulate in vivo. These forms include apo-IscU, [2Fe-2S] cluster-loaded IscU, and IscU complexed with IscS. An ability to produce a dimeric [4Fe-4S] cluster-loaded form of IscU by using in vitro reconstitution methods has been reported previously (9, 18) . However, no significant accumulation of a [4Fe-4S] cluster-loaded IscU species produced in vivo was recognized in the current work. It is possible that a [4Fe-4S] cluster-loaded form of IscU, if produced in vivo, exists in concentrations too low to be observed by the methods used here, is too labile for purification, or is very short-lived when produced in vivo. Our second experimental strategy was aimed at determining the biochemical basis for the dominant-negative phenotype associated with the IscU Asp 39 -substituted protein (11) . Isolation of the substituted form of IscU revealed that it is purified as a noncovalent, nondissociating, stoichiometric complex with IscS and that it contains an [Fe-S] species that is resistant to oxidative degradation. The dominant-negative phenotype associated with the IscU Ala 39 substitution can, therefore, be attributed to an inability for the release of [Fe-S] clusters assembled on IscU, as well as the sequestering of IscS, such that it is not available for other intracellular S-trafficking functions. The nearly exact stoichiometry of the IscU-Ala 39 -IscS complex suggests that there is only one IscU subunit associated with each cysteine desulfurase active site contained within the IscS homodimer. Crystallographically determined structures of IscS have revealed that the active sites are located on opposite sides of the IscS homodimer and are separated by Ϸ30 Å (19) . This finding indicates that [Fe-S] species are likely to be initially assembled on monomeric forms of IscU.
Another mechanistic insight to emerge is related to the observation that the nondissociating IscU-Ala 39 -IscS complex is isolated in a form that apparently contains [2Fe-2S] clusters. This finding suggests that the completion of [2Fe-2S] cluster assembly on the IscU scaffold does not necessarily occur through the sequential delivery of S atoms from IscS in a process that involves the association and dissociation of IscS and IscU. Rather, it would appear that [2Fe-2S] cluster assembly occurs either in a single step involving polysulfurated IscS or that sequential desulfurization steps occur within the IscU-IscS complex to achieve completion of [2Fe-2S] cluster assembly. With respect to the latter possibility, it is interesting that the overall activity of IscS is much lower when trapped in a complex with IscU. This feature could be related to restricted accessibility of the active site cysteine, which is contained on a flexible loop (19) for attack on the substrate cysteine-PLP adduct. The sequential events that occur during [Fe-S] cluster assembly have not been revealed by the present work. Nevertheless, our ability to isolate a [2Fe-2S] cluster form of IscU that is not associated with IscS indicates that IscU has the capacity to dissociate from IscS in vivo upon completion of [2Fe-2S] cluster assembly. 
Experimental Procedures
Strain and Plasmid Construction. The technical procedures involved in plasmid and strain constructions, including the construction of strain DJ1421, which served as the parental strain used in the present article, have been described in detail previously (11) . Strain DJ1601 carries an in-frame 120-bp deletion within the iscR gene, which removes residues 21-60 within IscR. Strain DJ1697 is isogenic with DJ1601 except that it contains an eight-histidine coding sequence (5Ј-TACCGCATCATCACCATCACCACCATCACG-3Ј) inserted at the StuI site of iscU, which is located at the C-terminal coding region of iscU. Strain DJ1766 carries the same polyhistidine encoding tag as DJ1697 and also has the Asp 39 codon (GAC) of iscU substituted by an Ala 39 codon (GCC). DJ1766 also carries an insertion element within the recA gene to ensure strain stability (11) . The relevant genomic regions of strains DJ1421, DJ1601, DJ1697, and DJ1766 are shown in Fig. 1 , all of which were confirmed by DNA sequence analysis of PCR-amplified genomic DNA. Two strains were used to assess the effect of an iscR deletion on ISC gene expression. The first of these, DJ1525, is isogenic with DJ1421 except that it contains a ⌽(hscAЈ-lacZ) fusion within the endogenous ISC gene cluster. The other strain, DJ1580, carries the same ⌽(hscAЈ-lacZ) fusion as DJ1525, and it also carries a 186-bp in-frame deletion within iscR removing codons 57-119. Construction of similar strains that carry the same ⌽(hscAЈ-lacZ) fusion placed within DJ1525 and DJ1580 have been described in detail in ref. 11 . Heterologous production of the A. vinelandii IscS and His-tagged IscU-Ala 39 protein in E. coli was accomplished by using a derivative of the plasmid vector pAra13 (20) , which has the expression of these genes placed under control of the ara regulatory elements. For construction of this plasmid, pDB1712, a BspHI-HindIII fragment that contains iscS, iscU, and a portion of iscA, was used. Cell growth and arabinose-stimulated gene expression was performed as described in ref. 20 .
Growth and Purification of IscU and the IscU-Ala 39 -IscS Complex Produced by
Strains DJ1697 and DJ1766. A. vinelandii cells were grown at 30°C in Burk's medium (21) supplemented with 10 mM urea in a 150-liter fermenter. Harvested cells (100 -200 g wet weight) were resuspended in 1.5 vol of degassed, argonsparged, 50 mM Tris⅐HCl (pH 8.0) (buffer A) containing 0.5 M NaCl, pepstatin A (0.14 mg/liter), and phenylmethanesulfonyl fluoride (0.5 mM) and lysed by one or two passages through a Nano DeBee homogenizer at 25,000 psi (B.E.E. International). Crude extracts were obtained by centrifuging cell lysates at 35,000 rpm for 1 h at 4°C in a Beckman Coulter Optima LE-80K ultracentrifuge using a TI 45 rotor. All subsequent IscU purification steps using DJ1697 extracts were performed in a Coy anaerobic chamber containing a gas mixture of 4% H 2 and 96% N 2 , whereas purification of the IscU-Ala 39 -IscS complex produced by DJ1766 was performed on the bench top under anoxic conditions maintained by using a Schlenk line and degassed argon-sparged buffers. Cell extracts were applied to XK-16 or XK-26 Amersham Pharmacia Biotech columns respectively packed with either 5 or 15 ml of IMAC resin. IMAC columns were charged with 50 mM NiSO 4 and equilibrated with 5 vol of the above buffer before loading crude extracts. In the case of DJ1697 extracts, bound protein was sequentially washed with three column volumes of buffer A containing 0.5 M NaCl, three column volumes of buffer A containing 0.1 M NaCl and 20 mM imidazole, and then eluted by using buffer A containing 0.1 M NaCl and 200 mM imidazole. In the case of DJ1766 extracts, bound protein was washed with three column volumes of buffer A containing 0.5 M NaCl and 20 mM imidazole, three column volumes containing 0.5 M NaCl and 40 mM imidazole, and then eluted with buffer A containing 0.5 M NaCl and 100 mM imidazole.
Typical protein yields using this procedure were 2 nmol of IscU per gram of cell paste and 9 nmol of IscUS per gram of cell paste from DJ1697 and DJ1766, respectively.
For further separation of the IMAC fraction that contains IscU produced by DJ1697, the sample was diluted 10-fold in buffer A containing 1 mM DTT and applied to a 1-ml HiTrap Q HP column (GE Healthcare) and washed with 10 volumes of the same buffer. IscU was subsequently eluted by using a 10-ml 0 -200 mM NaCl gradient in buffer A containing 1 mM DTT. The remaining bound protein, identified as IscS, was subsequently eluted from the column using buffer A that contains 1 M NaCl and 1 mM DTT. A representative elution profile is shown in Fig. 2 .
For further purification of the IMAC fraction that contains the IscU Ala 39 -IscS complex produced by strain DJ1766, the sample was diluted 5-fold with buffer A containing 0.5 mM tris(2-carboxyethyl)phosphine and applied to a 5-ml, 1.5 ϫ 3.0-cm Q-Sepharose anion-exchange column (GE Healthcare). The loaded column was washed with approximately 5 vol of buffer A containing 150 mM NaCl and subsequently eluted with buffer A containing 400 mM NaCl.
Purification of recombinantly expressed IscS in E. coli was performed essentially as reported in ref. 22 , with the exception that 10% glycerol was added to the buffers and the protein was stored in 0.6 M NaCl.
Gel-Exclusion Chromatography.
A prepacked Superose 12 gel-filtration column (GE Healthcare) was used to estimate the Mr of IscU purified from DJ1697 and the IscU-Ala 39 -IscS complex prepared from DJ1766. The column was preequilibrated with a degassed and argon-sparged 20 mM Tris⅐HCl buffer (pH 7.8) containing 0.2 M NaCl. Then, Ϸ0.5 mg was applied to the column and subsequently eluted by using a flow rate of 0.5 ml/min.
Analytical and Spectroscopic Analyses. Protein concentration was determined by using either the biuret method or the Bio-Rad protein assay. All analytical analyses were performed in triplicate. Iron was quantified by using the commercial Quantichrom iron assay kit (DIFE-250) purchased from Bioassay Systems. Sulfide and PLP quantifications were performed as described previously (23, 24) . UV-visible absorption spectroscopy analyses were performed at room temperature by using a Cary 50 Bio Spectrophotometer. For amino acid analysis, 25 g of the IscU Ala 39 -IscS complex was separated by SDS/PAGE. Stained bands corresponding to IscU and IscS were excised and delivered to the Keck Biotechnology Resource Laboratory (Yale University, New Haven, CT) for quantitative amino acid analysis using a Hitachi L-8900 amino acid analyzer. Western blot analysis was performed as described in ref. 11 , and densitometry measurements were obtained by using a ChemiXRS imager from Bio-Rad.
Enzyme Assays and Kinetic Analyses. All assays were performed at room temperature. Aconitase, isocitrate dehydrogenase, and ␤-galactosidase activities were measured by using the same procedures described in ref. 11 . Substrate affinity was evaluated by monitoring the immediate ⌬A400 elicited by the addition of increasing concentrations of L-cysteine to 50 nmol of IscS or the IscU-Ala 39 -IscS complex. The ⌬A 400 values were standardized to the amount of PLP present in each protein sample. The time-dependent relaxation of the ⌬A400 induced by the addition of a 10-fold molar excess of L-cysteine to either IscS or the IscU-Ala 39 -IscS complex was obtained by recording the UV-visible spectrum every 20 s after substrate addition.
Mass Spectrometry. Mass spectra were obtained through the Virginia Tech proteomics research incubator service. Collision-induced LC/MS/MS spectra were obtained from trypsin-digested samples, and data were processed by Xcalibur version 1.2 software.
